|
|
|
Publications in Math-Net.Ru |
Citations |
|
2025 |
| 1. |
N. S. Volkova, A. A. Larenkov, N. S. Boutakova, E. K. Beloglazkina, A. E. Machulkin, “Synthesis of a pteroic-based conjugate with ibuprofen moiety and macrocyclic chelator DOTA-GA”, Mendeleev Commun., 35:6 (2025), 670–672  |
| 2. |
N. Yu. Zyk, A. Yu. Kolchanova, N. S. Volkova, A. A. Uspenskaia, D. A. Skvortsov, E. K. Beloglazkina, N. V. Zyk, A. G. Majouga, A. E. Machulkin, “A novel molecular platform for co-delivery of monomethyl auristatin E and ispinesib to prostate cancer cells”, Mendeleev Commun., 35:4 (2025), 440–443   |
| 3. |
A. A. Uspenskaia, I. A. Doroshenko, K. A. Popovicheva, N. V. Shmychkov, I. I. Levina, M. K. Beklemishev, V. N. Tashlitsky, T. A. Podrugina, A. E. Machulkin, E. K. Beloglazkina, “Fluorescent conjugates of PSMA-targeting ligand with cyanine dyes: synthetic approaches and photochemical properties”, Mendeleev Commun., 35:2 (2025), 172–175 |
|
2023 |
| 4. |
N. Yu. Zyk, S. A. Petrov, M. V. Zavertkina, A. A. Uspenskaya, P. A. Krasnikov, N. S. Dashkova, E. K. Beloglazkina, A. G. Majouga, N. V. Zyk, A. E. Machulkin, “Choice of the optimal synthetic approach for the polypeptide ligands of prostatic specific membrane antigen preparation”, Mendeleev Commun., 33:4 (2023), 472–475 |
6
|
|
2020 |
| 5. |
A. A. Uspenskaia, A. E. Machulkin, E. A. Nimenko, R. R. Shafikov, S. A. Petrov, D. A. Skvortsov, E. K. Beloglazkina, A. G. Majouga, “Influence of the dipeptide linker configuration on the activity of PSMA ligands”, Mendeleev Commun., 30:6 (2020), 756–759 |
8
|
|
| Organisations |
|
|
